BNP PARIBAS FINANCIAL MARKETS - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$85,792,000
+100831.8%
29,789
+186081.2%
0.00%
Q2 2021$85,000
+14.9%
160.0%0.00%
Q1 2021$74,000
+39.6%
160.0%0.00%
Q4 2020$53,0000.0%160.0%0.00%
Q3 2020$53,000
-100.0%
16
-100.0%
0.00%
Q2 2020$173,899,000
+539.9%
51,602
+627.3%
0.00%
Q1 2020$27,174,000
+36.3%
7,095
+114.9%
0.00%
Q4 2019$19,944,000
-0.3%
3,302
+24.7%
0.00%
Q3 2019$20,011,000
+2404.5%
2,647
+4386.4%
0.00%
Q2 2019$799,000
-44.4%
59
-77.7%
0.00%
Q1 2019$1,436,000
+82.5%
2650.0%0.00%
Q4 2018$787,000
-64.4%
265
-2.2%
0.00%
Q3 2018$2,211,000
-16.2%
2710.0%0.00%
Q2 2018$2,640,000
-88.2%
271
-89.5%
0.00%
Q1 2018$22,333,000
-29.2%
2,570
+2.0%
0.00%
Q4 2017$31,550,000
+239.1%
2,520
+126.4%
0.00%
Q3 2017$9,305,000
-54.1%
1,113
-6.9%
0.00%
Q2 2017$20,279,000
+101295.0%
1,195
+119400.0%
0.00%
Q1 2017$20,000
+25.0%
10.0%0.00%
Q4 2016$16,000
+23.1%
10.0%0.00%
Q3 2016$13,000
+85.7%
10.0%0.00%
Q2 2016$7,000
-98.7%
1
-98.2%
0.00%
Q1 2016$539,000
-91.6%
57
-91.1%
0.00%
Q4 2015$6,444,000
-29.6%
6400.0%0.00%
Q3 2015$9,158,0006400.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 1,510,872$800,7620.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 122,892$65,1330.01%
Bernardo Wealth Planning LLC 38,578$20,4460.01%
Key FInancial Inc 7,500$5,4900.00%
Penserra Capital Management LLC 215,722$1140.00%
King Wealth Management Group 16,000$80.00%
Newbridge Financial Services Group, Inc. 6,075$3,2200.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 115,900$61,4270.00%
ZEKE CAPITAL ADVISORS, LLC 49,700$26,3410.00%
Founders Capital Management 2,000$10.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders